In the differential diagnosis of AD versus PDD, serum SV2A demonstrated a high diagnostic AUC, which was significantly higher than those of GFAP (p = 0.0430), NfL (p = 0.0009), and p-tau217 (p < 0.0001) (Additional file 1: Table S5). This evidence concerns the gene SV2A and Alzheimer disease.